Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Windisch

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Journal of Neural Transmission (Vienna, Austria : 1996)|January 20, 2005
Amelioration of the cerebrovascular amyloidosis in a transgenic model of Alzheimer's disease with the neurotrophic compound cerebrolysinE Rockenstein, A Adame, M Mante, et al.
Orvosi Hetilap|August 11, 2000
[New method for the intraoperative biochemical monitoring of cerebrospinal fluid in surgery of thoracoabdominal aortic aneurysms]G Nagy, C Dzsinich, G Sepa, et al.
Journal of Neural Transmission. Supplementum|November 29, 2002
Vitamin E binding protein afamin protects neuronal cells in vitroM Heiser, B Hutter-Paier, L Jerkovic, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 31, 2009
Randomized, crossover, single-blind, placebo-controlled, human pharmacology clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: multiple-dose pharmacokineticsJ Algorta, M A Pena, A Alvarez, et al.
Methods and Findings in Experimental and Clinical Pharmacology|November 1, 2005
Neuropeptide dietary supplement N-PEP-12 enhances cognitive function and activates brain bioelectrical activity in healthy elderly subjectsX A Alvarez, L Corzo, M Laredo, et al.
Methods and Findings in Experimental and Clinical Pharmacology|June 19, 2008
Phase I clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: tolerance and pharmacokinetics study of escalating single oral dosesJ Algorta, M A Pena, C Maraschiello, et al.
Journal of Neural Transmission. Supplementum|August 29, 2000
Cerebrolysin reduces microglial activation in vivo and in vitro: a potential mechanism of neuroprotectionX A Alvarez, V R Lombardi, L Fernández-Novoa, et al.
Basic Research in Cardiology|March 1, 1991
Comparison of acute electrophysiological effects of amiodarone and its metabolite desethylamiodarone in Langendorff perfused guinea pig heartsG Stark, U Stark, M Windisch, et al.
Cardiovascular Research|October 1, 1991
Acute effects of amiodarone on ultrastructure and electrical activity of isolated guinea pig heartsG Stark, M Windisch, E M Haller, et al.
Wiener Klinische Wochenschrift. Supplementum|January 1, 1992
Results of the multicenter evaluation of a homogeneous immunoassay for digitoxin based on the cloned enzyme donor immunoassay technologyJ Jarausch, Y Cano, E Hammer, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Journal of Neural Transmission (Vienna, Austria : 1996)|January 20, 2005
Amelioration of the cerebrovascular amyloidosis in a transgenic model of Alzheimer's disease with the neurotrophic compound cerebrolysinE Rockenstein, A Adame, M Mante, et al.
Orvosi Hetilap|August 11, 2000
[New method for the intraoperative biochemical monitoring of cerebrospinal fluid in surgery of thoracoabdominal aortic aneurysms]G Nagy, C Dzsinich, G Sepa, et al.
Journal of Neural Transmission. Supplementum|November 29, 2002
Vitamin E binding protein afamin protects neuronal cells in vitroM Heiser, B Hutter-Paier, L Jerkovic, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 31, 2009
Randomized, crossover, single-blind, placebo-controlled, human pharmacology clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: multiple-dose pharmacokineticsJ Algorta, M A Pena, A Alvarez, et al.
Methods and Findings in Experimental and Clinical Pharmacology|November 1, 2005
Neuropeptide dietary supplement N-PEP-12 enhances cognitive function and activates brain bioelectrical activity in healthy elderly subjectsX A Alvarez, L Corzo, M Laredo, et al.
Methods and Findings in Experimental and Clinical Pharmacology|June 19, 2008
Phase I clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: tolerance and pharmacokinetics study of escalating single oral dosesJ Algorta, M A Pena, C Maraschiello, et al.
Journal of Neural Transmission. Supplementum|August 29, 2000
Cerebrolysin reduces microglial activation in vivo and in vitro: a potential mechanism of neuroprotectionX A Alvarez, V R Lombardi, L Fernández-Novoa, et al.
Basic Research in Cardiology|March 1, 1991
Comparison of acute electrophysiological effects of amiodarone and its metabolite desethylamiodarone in Langendorff perfused guinea pig heartsG Stark, U Stark, M Windisch, et al.
Cardiovascular Research|October 1, 1991
Acute effects of amiodarone on ultrastructure and electrical activity of isolated guinea pig heartsG Stark, M Windisch, E M Haller, et al.
Wiener Klinische Wochenschrift. Supplementum|January 1, 1992
Results of the multicenter evaluation of a homogeneous immunoassay for digitoxin based on the cloned enzyme donor immunoassay technologyJ Jarausch, Y Cano, E Hammer, et al.
Pageof 9